FDA Launches Pilot to Boost U.S. Generic Drug Manufacturing
Key Takeaways: Launch Date: October 6, 2025 Objective: Accelerate review timelines for Abbreviated New Drug Applications (ANDAs) for generics manufactured…
Latest Updates on New Manufacturing Plants in USA and Compliance Regulations
Key Takeaways: Launch Date: October 6, 2025 Objective: Accelerate review timelines for Abbreviated New Drug Applications (ANDAs) for generics manufactured…
Key Takeaways Stellantis is channeling USD 10 Billion into its U.S. operations, including USD 5 Billion in new investment. Funds…
In modern times, sustainability in manufacturing is crucial for U.S. plants due to rising consumer demand and tightening regulations. Consumers…
Key Takeaways: AbbVie is investing more than $10 billion in U.S. manufacturing, with a focus on immunology, oncology, and neuroscience…
In the United States, the growing role of technology in manufacturing is reshaping the industry. According to an industry survey,…
Key Takeaways Production Milestone: Boviet Solar has successfully completed installation of its third manufacturing line in Greenville, North Carolina, bringing…
The manufacturing landscape in the United States presents a unique set of opportunities and challenges for companies. As businesses consider…
Key Takeaways Strategic Acquisition: Celltrion USA finalizes USD 330 Million purchase of FDA-approved biopharmaceutical manufacturing facility from Eli Lilly in…
Key Takeaways Massive Investment Commitment: Gilead Sciences announces comprehensive USD 32 Billion investment program spanning through 2030 to bolster U.S.…
Key Takeaways Major Capital Investment: NVIDIA commits USD 5 Billion equity investment in Intel at USD 23.28 per share to…